CUSHING’S SYNDROME FROM CONCOMITANT THERAPY OF RITONAVIR AND FLUTICASONE
Keywords:
Cushing’s syndrome, protease inhibitor, ritonavir, fluticasone, HIVAbstract
CASE
The most common cause of Cushing’s syndrome (CS) is exogenous steroid use. We present a 9-year-old female with CS from a drug interaction between an intranasal steroid (INS) and a protease inhibitor. She was treated for HIV with zidovudine, lamivudine, and lopinavir/ritonavir. At the age of 6.5 years, she had used intranasal fluticasone furoate to control allergic rhinitis. She had poor linear growth and she became extremely short. She has truncal obesity, a moon face, and purplish abdominal striae at the age of nine. The 8 a.m. serum cortisol level was less than 0.05 mcg/dL, with no response to the 1 mcg ACTH stimulation test. Thus, exogenous CS was diagnosed. Ritonavir inhibits the hepatic CYP3A4 isozyme resulting in decreased glucocorticoid metabolism. Interaction between ritonavir and fluticasone was suspected as the cause of CS. After the withdrawal of INS, the clinical features of CS improved. Therefore, children receiving antiretroviral medication should use steroids with caution.
Downloads
References
*
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Pontipa Engkakul, Pornumpa Bunjoungmanee, Wiraporn Yodvisitsak, Auchara Tangsathapornpong
![Creative Commons License](http://i.creativecommons.org/l/by-nc/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of the ASEAN Federation of Endocrine Societies is licensed under a Creative Commons Attribution-NonCommercial 4.0 International. (full license at this link: http://creativecommons.org/licenses/by-nc/3.0/legalcode).
To obtain permission to translate/reproduce or download articles or use images FOR COMMERCIAL REUSE/BUSINESS PURPOSES from the Journal of the ASEAN Federation of Endocrine Societies, kindly fill in the Permission Request for Use of Copyrighted Material and return as PDF file to jafes@asia.com or jafes.editor@gmail.com.
A written agreement shall be emailed to the requester should permission be granted.